English

FERMAVIR PHARMACEUTICALS, INC.

EDGAR

Filing (10KSB) · filed 2007-08-03

14 filing records in this dataset, filed from 2004-12-14 to 2007-08-03. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2007-04-30 · USD

Exact inputs and evidence

Revenue: 0 USD Source
Revenue: 0 USD Source

Operating cash flow

-773 thousand USD

2007-04-30 · USD

Exact inputs and evidence

Operating Cash Flow: -2051918 USD Source
Operating Cash Flow: -1278609 USD Source

Free cash flow

-773 thousand USD

2007-04-30 · USD

Exact inputs and evidence

Operating Cash Flow: -2051918 USD Source
Operating Cash Flow: -1278609 USD Source
Capital Expenditure: 0 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 480 thousand USD 2007-04-30 Source
Exact value

480199 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

2006-05-01 – 2007-04-30

Exact inputs and evidence

Revenue: 0 USD · 2006-05-01 – 2006-07-31 Source
Revenue: 0 USD · 2006-08-01 – 2006-10-31 Source
Revenue: 0 USD · 2006-11-01 – 2007-01-31 Source
Revenue: 0 USD · 2006-05-01 – 2007-04-30 Source
Revenue: 0 USD · 2006-05-01 – 2007-01-31 Source

Net income

-12.3 million USD

2006-05-01 – 2007-04-30

Exact inputs and evidence

Net income: -493294 USD · 2006-05-01 – 2006-07-31 Source
Net income: -573332 USD · 2006-08-01 – 2006-10-31 Source
Net income: -4225949 USD · 2006-11-01 – 2007-01-31 Source
Net income: -12336884 USD · 2006-05-01 – 2007-04-30 Source
Net income: -5292575 USD · 2006-05-01 – 2007-01-31 Source

Operating cash flow

-2.05 million USD

2006-05-01 – 2007-04-30

Exact inputs and evidence

Operating cash flow: -249696 USD · 2006-05-01 – 2006-07-31 Source
Operating cash flow: -394235 USD · 2006-05-01 – 2006-10-31 Source
Operating cash flow: -249696 USD · 2006-05-01 – 2006-07-31 Source
Operating cash flow: -1278609 USD · 2006-05-01 – 2007-01-31 Source
Operating cash flow: -394235 USD · 2006-05-01 – 2006-10-31 Source
Operating cash flow: -2051918 USD · 2006-05-01 – 2007-04-30 Source
Operating cash flow: -1278609 USD · 2006-05-01 – 2007-01-31 Source

Capital expenditure

0 USD

2006-05-01 – 2007-04-30

Exact inputs and evidence

Capital expenditure: 0 USD · 2006-05-01 – 2006-07-31 Source
Capital expenditure: 0 USD · 2006-05-01 – 2006-10-31 Source
Capital expenditure: 0 USD · 2006-05-01 – 2006-07-31 Source
Capital expenditure: 0 USD · 2006-05-01 – 2007-01-31 Source
Capital expenditure: 0 USD · 2006-05-01 – 2006-10-31 Source
Capital expenditure: 0 USD · 2006-05-01 – 2007-04-30 Source
Capital expenditure: 0 USD · 2006-05-01 – 2007-01-31 Source

Free cash flow

-2.05 million USD

2006-05-01 – 2007-04-30

Exact inputs and evidence

Operating cash flow: -249696 USD · 2006-05-01 – 2006-07-31 Source
Operating cash flow: -394235 USD · 2006-05-01 – 2006-10-31 Source
Operating cash flow: -249696 USD · 2006-05-01 – 2006-07-31 Source
Operating cash flow: -1278609 USD · 2006-05-01 – 2007-01-31 Source
Operating cash flow: -394235 USD · 2006-05-01 – 2006-10-31 Source
Operating cash flow: -2051918 USD · 2006-05-01 – 2007-04-30 Source
Operating cash flow: -1278609 USD · 2006-05-01 – 2007-01-31 Source
Capital expenditure: 0 USD · 2006-05-01 – 2006-07-31 Source
Capital expenditure: 0 USD · 2006-05-01 – 2006-10-31 Source
Capital expenditure: 0 USD · 2006-05-01 – 2006-07-31 Source
Capital expenditure: 0 USD · 2006-05-01 – 2007-01-31 Source
Capital expenditure: 0 USD · 2006-05-01 – 2006-10-31 Source
Capital expenditure: 0 USD · 2006-05-01 – 2007-04-30 Source
Capital expenditure: 0 USD · 2006-05-01 – 2007-01-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2007-08-03.

Financial data available through: 2007-04-30.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2007-04-30
Operating income: 5 of 11 periods available· newest 2007-04-30
Net income: 5 of 11 periods available· newest 2007-04-30
Operating cash flow: 5 of 11 periods available· newest 2007-04-30
Capital expenditure: 5 of 11 periods available· newest 2007-04-30
Total assets: 4 of 11 periods available· newest 2007-04-30
Total liabilities: 4 of 11 periods available· newest 2007-04-30
Current assets: 4 of 11 periods available· newest 2007-04-30
Current liabilities: 3 of 11 periods available· newest 2007-04-30
Cash and cash equivalents: 5 of 11 periods available· newest 2007-04-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
USD 0

Prior period

USD 0

2005-05-01 – 2006-04-30
Current period

USD 0

2006-05-01 – 2007-04-30

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 2005-05-01 – 2006-04-30
Inspect prior input Prior source
0 USD · 2006-05-01 – 2007-04-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · FERMAVIR PHARMACEUTICALS, INC. · 2007-04-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Year-over-year change in Revenue: 0 USD Concept: fundies:Revenue Period: 2006-05-01 to 2007-04-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (2006-05-01 to 2007-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-07-058639.txt#8193 Input fundies:Revenue: 0 USD (2005-05-01 to 2006-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-07-058639.txt#8193
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 6.78 million

Prior period

−USD 5.56 million

2005-05-01 – 2006-04-30
Current period

−USD 12.34 million

2006-05-01 – 2007-04-30

Exact inputs and evidence

-12336884 − -5557611 = -6779273 USD

-5557611 USD · 2005-05-01 – 2006-04-30
Inspect prior input Prior source
-12336884 USD · 2006-05-01 – 2007-04-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · FERMAVIR PHARMACEUTICALS, INC. · 2007-04-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Year-over-year change in Net income: -6779273 USD Concept: fundies:NetIncome Period: 2006-05-01 to 2007-04-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -12336884 USD (2006-05-01 to 2007-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-07-058639.txt#11510 Input fundies:NetIncome: -5557611 USD (2005-05-01 to 2006-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-07-058639.txt#11510
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 744,038

Prior period

−USD 1.31 million

2005-05-01 – 2006-04-30
Current period

−USD 2.05 million

2006-05-01 – 2007-04-30

Exact inputs and evidence

-2051918 − -1307880 = -744038 USD

-1307880 USD · 2005-05-01 – 2006-04-30
Inspect prior input Prior source
-2051918 USD · 2006-05-01 – 2007-04-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · FERMAVIR PHARMACEUTICALS, INC. · 2007-04-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Year-over-year change in Operating cash flow: -744038 USD Concept: fundies:OperatingCashFlow Period: 2006-05-01 to 2007-04-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -2051918 USD (2006-05-01 to 2007-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-07-058639.txt#12206 Input fundies:OperatingCashFlow: -1307880 USD (2005-05-01 to 2006-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-07-058639.txt#12206
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-100%

Prior period

USD 27,052

2005-05-01 – 2006-04-30
Current period

USD 0

2006-05-01 – 2007-04-30

Exact inputs and evidence

0 − 27052 = -27052 USD

27052 USD · 2005-05-01 – 2006-04-30
Inspect prior input Prior source
0 USD · 2006-05-01 – 2007-04-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · FERMAVIR PHARMACEUTICALS, INC. · 2007-04-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Year-over-year change in Capital expenditure: -27052 USD Concept: fundies:CapitalExpenditure Period: 2006-05-01 to 2007-04-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 0 USD (2006-05-01 to 2007-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-07-058639.txt#12271 Input fundies:CapitalExpenditure: 27052 USD (2005-05-01 to 2006-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-07-058639.txt#12271
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2007 2006-05-01 – 2007-04-30

Revenue USD 0
Operating costs Derived USD 4.37 million
Operating income −USD 4.37 million
Tax, interest and other Derived USD 7.96 million
Net income −USD 12.34 million

Cash

Operating cash flow −USD 2.05 million
Capital expenditure USD 0
Free cash flow Derived −USD 2.05 million

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2005 Not shown: operating income or net income is not reported.
2005 Not shown: operating income or net income is not reported.
2006 Not shown: operating income or net income is not reported.
2006 Not shown: operating income or net income is not reported.
2007 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2005 2004-05-01 – 2005-04-30	24117 Derived	-24117	0 Derived	-24117	-14117 Derived	Source 2004-05-01 – 2005-04-30: 0 USD Inspect Revenue Open source 2004-05-01 – 2005-04-30: -24117 USD Inspect Operating Income Open source 2004-05-01 – 2005-04-30: -24117 USD Inspect Net Income Open source 2004-05-01 – 2005-04-30: -14117 USD Inspect Operating Cash Flow Open source 2004-05-01 – 2005-04-30: 0 USD Inspect Capital Expenditure Open source
2005 2004-07-01 – 2005-06-30	24117 Derived	-24117	0 Derived	-24117	-14117 Derived	Source 2004-07-01 – 2005-06-30: 0 USD Inspect Revenue Open source 2004-07-01 – 2005-06-30: -24117 USD Inspect Operating Income Open source 2004-07-01 – 2005-06-30: -24117 USD Inspect Net Income Open source 2004-07-01 – 2005-06-30: -14117 USD Inspect Operating Cash Flow Open source 2004-07-01 – 2005-06-30: 0 USD Inspect Capital Expenditure Open source
2006 2005-05-01 – 2006-04-30	5417987 Derived	-5417987	139624 Derived	-5557611	-1334932 Derived	Source 2005-05-01 – 2006-04-30: 0 USD Inspect Revenue Open source 2005-05-01 – 2006-04-30: -5417987 USD Inspect Operating Income Open source 2005-05-01 – 2006-04-30: -5557611 USD Inspect Net Income Open source 2005-05-01 – 2006-04-30: -1307880 USD Inspect Operating Cash Flow Open source 2005-05-01 – 2006-04-30: 27052 USD Inspect Capital Expenditure Open source
2006 2005-07-01 – 2006-06-30	5417987 Derived	-5417987	139624 Derived	-5557611	-1334932 Derived	Source 2005-07-01 – 2006-06-30: 0 USD Inspect Revenue Open source 2005-07-01 – 2006-06-30: -5417987 USD Inspect Operating Income Open source 2005-07-01 – 2006-06-30: -5557611 USD Inspect Net Income Open source 2005-07-01 – 2006-06-30: -1307880 USD Inspect Operating Cash Flow Open source 2005-07-01 – 2006-06-30: 27052 USD Inspect Capital Expenditure Open source
2007 2006-05-01 – 2007-04-30	4373779 Derived	-4373779	7963105 Derived	-12336884	-2051918 Derived	Source 2006-05-01 – 2007-04-30: 0 USD Inspect Revenue Open source 2006-05-01 – 2007-04-30: -4373779 USD Inspect Operating Income Open source 2006-05-01 – 2007-04-30: -12336884 USD Inspect Net Income Open source 2006-05-01 – 2007-04-30: -2051918 USD Inspect Operating Cash Flow Open source 2006-05-01 – 2007-04-30: 0 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2007

Values and sources

Revenue values and source evidence
Period	Series	Source evidence
20052005-04-30	Revenue	Revenue: 0 Open source
20052005-06-30	Revenue	Revenue: 0 Open source
20062006-04-30	Revenue	Revenue: 0 Open source
20062006-06-30	Revenue	Revenue: 0 Open source
20072007-04-30	Revenue	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20052005-04-30	Year over year	No prior comparable period	Revenue: 0 Open source
20052005-06-30	Year over year	No prior comparable period	Revenue: 0 Open source
20062006-04-30	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20062006-06-30	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20072007-04-30	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20052005-04-30	Operating margin	Not reported	Operating Income: -24117 Open source Revenue: 0 Open source
20052005-06-30	Operating margin	Not reported	Operating Income: -24117 Open source Revenue: 0 Open source
20062006-04-30	Operating margin	Not reported	Operating Income: -5417987 Open source Revenue: 0 Open source
20062006-06-30	Operating margin	Not reported	Operating Income: -5417987 Open source Revenue: 0 Open source
20072007-04-30	Operating margin	Not reported	Operating Income: -4373779 Open source Revenue: 0 Open source
20052005-04-30	Net margin	Not reported	Net Income: -24117 Open source Revenue: 0 Open source
20052005-06-30	Net margin	Not reported	Net Income: -24117 Open source Revenue: 0 Open source
20062006-04-30	Net margin	Not reported	Net Income: -5557611 Open source Revenue: 0 Open source
20062006-06-30	Net margin	Not reported	Net Income: -5557611 Open source Revenue: 0 Open source
20072007-04-30	Net margin	Not reported	Net Income: -12336884 Open source Revenue: 0 Open source
20052005-04-30	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -14117 Open source Capital Expenditure: 0 Open source
20052005-06-30	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -14117 Open source Capital Expenditure: 0 Open source
20062006-04-30	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -1307880 Open source Capital Expenditure: 27052 Open source
20062006-06-30	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -1307880 Open source Capital Expenditure: 27052 Open source
20072007-04-30	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -2051918 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -2.1M 2007

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-04-30	Operating cash flow	-14117	Operating Cash Flow: -14117 Open source
20052005-06-30	Operating cash flow	-14117	Operating Cash Flow: -14117 Open source
20062006-04-30	Operating cash flow	-1307880	Operating Cash Flow: -1307880 Open source
20062006-06-30	Operating cash flow	-1307880	Operating Cash Flow: -1307880 Open source
20072007-04-30	Operating cash flow	-2051918	Operating Cash Flow: -2051918 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -2.1M 2007

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-04-30	Free cash flow	-14117	Operating Cash Flow: -14117 Open source Capital Expenditure: 0 Open source
20052005-06-30	Free cash flow	-14117	Operating Cash Flow: -14117 Open source Capital Expenditure: 0 Open source
20062006-04-30	Free cash flow	-1334932	Operating Cash Flow: -1307880 Open source Capital Expenditure: 27052 Open source
20062006-06-30	Free cash flow	-1334932	Operating Cash Flow: -1307880 Open source Capital Expenditure: 27052 Open source
20072007-04-30	Free cash flow	-2051918	Operating Cash Flow: -2051918 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

183.7% 2007

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20052005-04-30	Liabilities / assets	4,464.3%	Total Liabilities: 10000 Open source Total Assets: 224 Open source
2005-06-30	Liabilities / assets	Not reported	No source recorded
20062006-04-30	Liabilities / assets	196.2%	Total Liabilities: 413900 Open source Total Assets: 210940 Open source
20062006-06-30	Liabilities / assets	196.2%	Total Liabilities: 413900 Open source Total Assets: 210940 Open source
20072007-04-30	Liabilities / assets	183.7%	Total Liabilities: 1075158 Open source Total Assets: 585284 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.5× 2007

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20052005-04-30	Current assets / current liabilities	0.02×	Current Assets: 224 Open source Current Liabilities: 10000 Open source
2005-06-30	Current assets / current liabilities	Not reported	No source recorded
20062006-04-30	Current assets / current liabilities	0.36×	Current Assets: 144560 Open source Current Liabilities: 401743 Open source
20062006-06-30	Current assets / current liabilities	Not reported	Current Assets: 144560 Open source
20072007-04-30	Current assets / current liabilities	0.5×	Current Assets: 528664 Open source Current Liabilities: 1057493 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2005 2004-05-01 – 2005-04-30	−USD 24,117 Exact value Exact value: -24117 USD 2004-05-01 – 2005-04-30: -24117 USD Inspect Net Income Open source Share or cite Citation for Net Income · FERMAVIR PHARMACEUTICALS, INC. · 2005-04-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Net Income: -24117 USD Concept: fundies:NetIncome Period: 2004-05-01 to 2005-04-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383/explain?concept=fundies%3ANetIncome&period=2005-04-30&surface=latest&period_type=duration&start=2004-05-01&unit=USD&dimensions= Input fundies:NetIncome: -24117 USD (2004-05-01 to 2005-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-06-055299.txt#10113 The citation records this snapshot. The page link may show a newer release later.	−USD 14,117 Exact value Exact value: -14117 USD 2004-05-01 – 2005-04-30: -14117 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FERMAVIR PHARMACEUTICALS, INC. · 2005-04-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Operating Cash Flow: -14117 USD Concept: fundies:OperatingCashFlow Period: 2004-05-01 to 2005-04-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383/explain?concept=fundies%3AOperatingCashFlow&period=2005-04-30&surface=latest&period_type=duration&start=2004-05-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14117 USD (2004-05-01 to 2005-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-06-055299.txt#10498 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2004-05-01 – 2005-04-30: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · FERMAVIR PHARMACEUTICALS, INC. · 2005-04-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2004-05-01 to 2005-04-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383/explain?concept=fundies%3ACapitalExpenditure&period=2005-04-30&surface=latest&period_type=duration&start=2004-05-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2004-05-01 to 2005-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-06-055299.txt#10603 The citation records this snapshot. The page link may show a newer release later.	−USD 14,117 Calculation and evidence -14117 − 0 USD Exact free cash flow: -14117 USD 2004-05-01 – 2005-04-30: -14117 USD · Inspect Operating Cash Flow · Source 2004-05-01 – 2005-04-30: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · FERMAVIR PHARMACEUTICALS, INC. · 2005-04-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Free cash flow: -14117 USD Concept: free-cash-flow Period: 2004-05-01 to 2005-04-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14117 USD (2004-05-01 to 2005-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-06-055299.txt#10498 Input fundies:CapitalExpenditure: 0 USD (2004-05-01 to 2005-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-06-055299.txt#10603 The citation records this snapshot. The page link may show a newer release later.
2005 2004-07-01 – 2005-06-30	−USD 24,117 Exact value Exact value: -24117 USD 2004-07-01 – 2005-06-30: -24117 USD Inspect Net Income Open source Share or cite Citation for Net Income · FERMAVIR PHARMACEUTICALS, INC. · 2005-06-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Net Income: -24117 USD Concept: fundies:NetIncome Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383/explain?concept=fundies%3ANetIncome&period=2005-06-30&surface=latest&period_type=duration&start=2004-07-01&unit=USD&dimensions= Input fundies:NetIncome: -24117 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-06-055563.txt#10094 The citation records this snapshot. The page link may show a newer release later.	−USD 14,117 Exact value Exact value: -14117 USD 2004-07-01 – 2005-06-30: -14117 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FERMAVIR PHARMACEUTICALS, INC. · 2005-06-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Operating Cash Flow: -14117 USD Concept: fundies:OperatingCashFlow Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383/explain?concept=fundies%3AOperatingCashFlow&period=2005-06-30&surface=latest&period_type=duration&start=2004-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14117 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-06-055563.txt#10479 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2004-07-01 – 2005-06-30: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · FERMAVIR PHARMACEUTICALS, INC. · 2005-06-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383/explain?concept=fundies%3ACapitalExpenditure&period=2005-06-30&surface=latest&period_type=duration&start=2004-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-06-055563.txt#10584 The citation records this snapshot. The page link may show a newer release later.	−USD 14,117 Calculation and evidence -14117 − 0 USD Exact free cash flow: -14117 USD 2004-07-01 – 2005-06-30: -14117 USD · Inspect Operating Cash Flow · Source 2004-07-01 – 2005-06-30: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · FERMAVIR PHARMACEUTICALS, INC. · 2005-06-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Free cash flow: -14117 USD Concept: free-cash-flow Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14117 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-06-055563.txt#10479 Input fundies:CapitalExpenditure: 0 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-06-055563.txt#10584 The citation records this snapshot. The page link may show a newer release later.
2006 2005-05-01 – 2006-04-30	−USD 5.56 million Exact value Exact value: -5557611 USD 2005-05-01 – 2006-04-30: -5557611 USD Inspect Net Income Open source Share or cite Citation for Net Income · FERMAVIR PHARMACEUTICALS, INC. · 2006-04-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Net Income: -5557611 USD Concept: fundies:NetIncome Period: 2005-05-01 to 2006-04-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383/explain?concept=fundies%3ANetIncome&period=2006-04-30&surface=latest&period_type=duration&start=2005-05-01&unit=USD&dimensions= Input fundies:NetIncome: -5557611 USD (2005-05-01 to 2006-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-07-058639.txt#11510 The citation records this snapshot. The page link may show a newer release later.	−USD 1.31 million Exact value Exact value: -1307880 USD 2005-05-01 – 2006-04-30: -1307880 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FERMAVIR PHARMACEUTICALS, INC. · 2006-04-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Operating Cash Flow: -1307880 USD Concept: fundies:OperatingCashFlow Period: 2005-05-01 to 2006-04-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383/explain?concept=fundies%3AOperatingCashFlow&period=2006-04-30&surface=latest&period_type=duration&start=2005-05-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1307880 USD (2005-05-01 to 2006-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-07-058639.txt#12206 The citation records this snapshot. The page link may show a newer release later.	USD 27,052 Exact value Exact value: 27052 USD 2005-05-01 – 2006-04-30: 27052 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · FERMAVIR PHARMACEUTICALS, INC. · 2006-04-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Capital Expenditure: 27052 USD Concept: fundies:CapitalExpenditure Period: 2005-05-01 to 2006-04-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383/explain?concept=fundies%3ACapitalExpenditure&period=2006-04-30&surface=latest&period_type=duration&start=2005-05-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 27052 USD (2005-05-01 to 2006-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-07-058639.txt#12271 The citation records this snapshot. The page link may show a newer release later.	−USD 1.33 million Calculation and evidence -1307880 − 27052 USD Exact free cash flow: -1334932 USD 2005-05-01 – 2006-04-30: -1307880 USD · Inspect Operating Cash Flow · Source 2005-05-01 – 2006-04-30: 27052 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · FERMAVIR PHARMACEUTICALS, INC. · 2006-04-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Free cash flow: -1334932 USD Concept: free-cash-flow Period: 2005-05-01 to 2006-04-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1307880 USD (2005-05-01 to 2006-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-07-058639.txt#12206 Input fundies:CapitalExpenditure: 27052 USD (2005-05-01 to 2006-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-07-058639.txt#12271 The citation records this snapshot. The page link may show a newer release later.
2006 2005-07-01 – 2006-06-30	−USD 5.56 million Exact value Exact value: -5557611 USD 2005-07-01 – 2006-06-30: -5557611 USD Inspect Net Income Open source Share or cite Citation for Net Income · FERMAVIR PHARMACEUTICALS, INC. · 2006-06-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Net Income: -5557611 USD Concept: fundies:NetIncome Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383/explain?concept=fundies%3ANetIncome&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:NetIncome: -5557611 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-06-055563.txt#10094 The citation records this snapshot. The page link may show a newer release later.	−USD 1.31 million Exact value Exact value: -1307880 USD 2005-07-01 – 2006-06-30: -1307880 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FERMAVIR PHARMACEUTICALS, INC. · 2006-06-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Operating Cash Flow: -1307880 USD Concept: fundies:OperatingCashFlow Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383/explain?concept=fundies%3AOperatingCashFlow&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1307880 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-06-055563.txt#10479 The citation records this snapshot. The page link may show a newer release later.	USD 27,052 Exact value Exact value: 27052 USD 2005-07-01 – 2006-06-30: 27052 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · FERMAVIR PHARMACEUTICALS, INC. · 2006-06-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Capital Expenditure: 27052 USD Concept: fundies:CapitalExpenditure Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383/explain?concept=fundies%3ACapitalExpenditure&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 27052 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-06-055563.txt#10584 The citation records this snapshot. The page link may show a newer release later.	−USD 1.33 million Calculation and evidence -1307880 − 27052 USD Exact free cash flow: -1334932 USD 2005-07-01 – 2006-06-30: -1307880 USD · Inspect Operating Cash Flow · Source 2005-07-01 – 2006-06-30: 27052 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · FERMAVIR PHARMACEUTICALS, INC. · 2006-06-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Free cash flow: -1334932 USD Concept: free-cash-flow Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1307880 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-06-055563.txt#10479 Input fundies:CapitalExpenditure: 27052 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-06-055563.txt#10584 The citation records this snapshot. The page link may show a newer release later.
2007 2006-05-01 – 2007-04-30	−USD 12.34 million Exact value Exact value: -12336884 USD 2006-05-01 – 2007-04-30: -12336884 USD Inspect Net Income Open source Share or cite Citation for Net Income · FERMAVIR PHARMACEUTICALS, INC. · 2007-04-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Net Income: -12336884 USD Concept: fundies:NetIncome Period: 2006-05-01 to 2007-04-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383/explain?concept=fundies%3ANetIncome&period=2007-04-30&surface=latest&period_type=duration&start=2006-05-01&unit=USD&dimensions= Input fundies:NetIncome: -12336884 USD (2006-05-01 to 2007-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-07-058639.txt#11510 The citation records this snapshot. The page link may show a newer release later.	−USD 2.05 million Exact value Exact value: -2051918 USD 2006-05-01 – 2007-04-30: -2051918 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FERMAVIR PHARMACEUTICALS, INC. · 2007-04-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Operating Cash Flow: -2051918 USD Concept: fundies:OperatingCashFlow Period: 2006-05-01 to 2007-04-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383/explain?concept=fundies%3AOperatingCashFlow&period=2007-04-30&surface=latest&period_type=duration&start=2006-05-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2051918 USD (2006-05-01 to 2007-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-07-058639.txt#12206 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2006-05-01 – 2007-04-30: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · FERMAVIR PHARMACEUTICALS, INC. · 2007-04-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2006-05-01 to 2007-04-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383/explain?concept=fundies%3ACapitalExpenditure&period=2007-04-30&surface=latest&period_type=duration&start=2006-05-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2006-05-01 to 2007-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-07-058639.txt#12271 The citation records this snapshot. The page link may show a newer release later.	−USD 2.05 million Calculation and evidence -2051918 − 0 USD Exact free cash flow: -2051918 USD 2006-05-01 – 2007-04-30: -2051918 USD · Inspect Operating Cash Flow · Source 2006-05-01 – 2007-04-30: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · FERMAVIR PHARMACEUTICALS, INC. · 2007-04-30 FERMAVIR PHARMACEUTICALS, INC. (edgar:1283383) Free cash flow: -2051918 USD Concept: free-cash-flow Period: 2006-05-01 to 2007-04-30 Values: Latest reported Published: 2026-11-04T21:03:52Z Snapshot: 6287a779b3193e95de2f56f9737be67e2a171061a4982e3dc31ec129ab65089f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1283383?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2051918 USD (2006-05-01 to 2007-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-07-058639.txt#12206 Input fundies:CapitalExpenditure: 0 USD (2006-05-01 to 2007-04-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1283383/0001104659-07-058639.txt#12271 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

14 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-04. Source filing dates and reporting periods are shown separately.

Identifiers: 0001283383, 1283383, edgar:1283383

Also known as VENUS BEAUTY SUPPLY INC

FERMAVIR PHARMACEUTICALS, INC.

Latest quarter

Revenue

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2007 2006-05-01 – 2007-04-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation